Jump to content

Drilldown: Medicines

Pharmacopedia
BrowseCategoriesLog in

Choose a table:


Medicines > classes: [[:Category:BPH_treatments|Benign prostatic hyperplasia treatment]] & fda max : 20 mg/d or 50 mg/day (no efficacy benefit shown for higher doses despite the 100 mg strength being available)

Use the filters below to narrow your results.

generic:
Terazosin (1)
brand:
Hytrin (US brand discontinued); mostly generic (1)
classes: (Click arrow to add another value)
mechanism:
'"`UNIQ--vote-0000111B-QINU`"' Intraoperative floppy iris syndrome is a recognized class effect. Recently emerging evidence (observational) suggests possible Parkinson's disease risk reduction via PGK1 binding — investigational and not a clinical indication'"`UNIQ--ref-0000111C-QINU`"'. (1)
uses:
'"`UNIQ--vote-0000111D-QINU`"', '"`UNIQ--vote-0000111E-QINU`"' (1)
starting dose:
1 mg PO at bedtime to limit first-dose syncope; titrate weekly to 5-10 mg (1)
preparations:
1, 2, 5, 10 mg capsules and tablets (1)
fda max: (Click arrow to add another value)
routes:
Oral (1)
onset:
BP and symptomatic LUTS improvement within 1-2 weeks (1)
duration:
24 hours (1)
halflife:
~12 hours'"`UNIQ--ref-0000111F-QINU`"' (1)
bioavailability:
>90% (oral; not significantly affected by food)'"`UNIQ--ref-00001120-QINU`"' (1)
pregnancy:
Limited data.<sup class="pcp-cn" title="This claim needs a citation.">&#91;[[Pharmacopedia:Citation needed|citation&nbsp;needed]]&#93;</sup> (1)
legal:
[[USLegal:Prescription only|Rx-only]] in US (1)

Showing below up to 1 result in range #1 to #1.

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)


View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://pharmacopedia.wiki/p/Special:Drilldown/Medicines"